about
Genome-wide methylation study on depression: differential methylation and variable methylation in monozygotic twinsBirth weight, working memory and epigenetic signatures in IGF2 and related genes: a MZ twin study.Birth Weight and Adult IQ, but Not Anxious-Depressive Psychopathology, Are Associated with Cortical Surface Area: A Study in Twins.Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-up Study.FKBP5 modulates the hippocampal connectivity deficits in depression: a study in twins.Family-based association study of common variants, rare mutation study and epistatic interaction detection in HDAC genes in schizophrenia.Increased familiarity of intellectual deficits in early-onset schizophrenia spectrum disorders.Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients.Family-based association study of neuregulin-1 gene and psychosis in a Spanish sample.Childhood abuse in the etiological continuum underlying psychosis from first-episode psychosis to psychotic experiences.The BDNF-Val66Met polymorphism modulates parental rearing effects on adult psychiatric symptoms: a community twin-based study.Neurotrophins role in depressive symptoms and executive function performance: Association analysis of NRN1 gene and its interaction with BDNF gene in a non-clinical sample.Evidence of an epistatic effect between Dysbindin-1 and Neuritin-1 genes on the risk for schizophrenia spectrum disorders.Familial aggregation of schizotypy in schizophrenia-spectrum disorders and its relation to clinical and neurodevelopmental characteristics.Further evidence of DEPDC7 DNA hypomethylation in depression: A study in adult twins.COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: A study in patients with schizophrenia and healthy subjects.Effect of the interleukin-1β gene on dorsolateral prefrontal cortex function in schizophrenia: a genetic neuroimaging study.Involvement of NRN1 gene in schizophrenia-spectrum and bipolar disorders and its impact on age at onset and cognitive functioning.Influence of DAOA and RGS4 genes on the risk for psychotic disorders and their associated executive dysfunctions: A family-based study.[Basic symptoms in schizophrenia, their clinical study and relevance in research].Effect of DISC1 polymorphisms on the long-term course of neurocognitive deficits in non-affective psychosis.Polymorphic variation in the epigenetic gene DNMT3B modulates the environmental impact on cognitive ability: a twin study.Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis.Two-year follow-up of treated adolescents with early-onset bipolar disorder: Changes in neurocognition.Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.Summary of the 1st Schizophrenia International Research Society Conference oral sessions, Venice, Italy, June 21-25, 2008: the rapporteur reports.Twin-based study of the complex interplay between childhood maltreatment, socioeconomic status and adult memory.New evidences of gene and environment interactions affecting prenatal neurodevelopment in schizophrenia-spectrum disorders: a family dermatoglyphic study.Neurodevelopmental liability to schizophrenia: the complex mediating role of age at onset and premorbid adjustment.Working memory in siblings of schizophrenia patients.The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study.Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 3-7 October 2010.Gene–environment interaction on cognition: A twin study of childhood maltreatment and COMT variabilityFamilial aggregation analysis of cognitive performance in early-onset bipolar disorderThe effect of the AKT1 gene and cannabis use on cognitive performance in healthy subjects
P50
Q30654005-9558BD15-7E8A-4A77-93F0-02EA7804D0D2Q34109666-B5E4ED1E-CCFC-4B57-8E2B-60C47570799DQ35667324-3F6469FF-6FAE-4068-996D-AF789B4A36ACQ36863662-8AD0550C-3103-45D7-ABBB-10B3271F40A9Q40071494-6511AC39-A5D2-4C6B-92EB-086754A4A536Q41760429-57DA6975-1053-4109-BF16-FA788E254891Q44234551-41CEB68F-AE73-4B99-A89E-E52AA94DE19BQ44274503-EBB92BAC-4988-4C65-BAC3-8EBFBAF645E8Q44466839-1269D4D6-42B1-4FC4-BB72-1FEF5FF3F50BQ47598039-097797F8-F719-4F03-B2C9-CCB8177CD4EEQ47649832-7EEC54B4-A9EC-44AD-8A22-28E12941C29CQ47822175-B4D2E3B7-D4FC-4787-8C5E-08DD5C9F608DQ47876684-09CCF5EB-F157-4D1B-BD3C-0C0BB891DB9CQ47908129-196D5AE2-9F7B-44E7-9843-8AFB815988E1Q48083612-8AFA4AD7-B05A-4B1B-812D-7E84D4E0F3DDQ48234097-93939573-CF82-4057-BB1A-3CAECA12E6E6Q48451200-726A567D-8177-4BFF-B9DD-68328CE4587FQ49106901-30586B90-F468-447C-B4AD-E26EAAC4588EQ50266625-1DA07DD7-A976-429B-AF3D-5B974A4D3B90Q50269157-D020E74F-6DC9-4A93-B124-88EEDA6C916BQ50435936-24F36B20-3AA5-4213-BDFD-5F0348AD1CBFQ50454768-9062D06C-E012-42A8-A341-2B042411A482Q50546206-353FFF43-6902-4A4A-B6A3-6B7129C4C77CQ50609498-20059152-A4EA-4645-89F9-20DB87F3B5B8Q50612716-13B39568-2BA2-42AC-A296-78622B86C42DQ50619710-5953952F-B9A4-49B2-BF02-E4C9701E1CF9Q50734293-2CB3121B-2C3C-470A-ADB8-EB160EC882F8Q51696672-C61D3C87-3332-4AD3-8CAB-5831421ADDB2Q51850905-84048703-F8C4-41EC-96C4-200E6DC09FB4Q51901574-0574469F-BB4C-4544-939A-DFDCE98DE733Q51922734-12399039-6EDD-40A5-9012-DA451329161DQ53154835-2E402E4C-13DD-46A2-9FFE-6EECA964D3BFQ61890778-375F4C2E-F1F4-48F2-B085-8126044032D7Q89689351-62CD92B7-D6C0-4A12-8CFE-EC5AEE6B7158Q96342915-92EA79B9-2ABF-4B57-BF04-86B829B653FC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
M Fatjó-Vilas
@ast
M Fatjó-Vilas
@en
M Fatjó-Vilas
@es
M Fatjó-Vilas
@nl
type
label
M Fatjó-Vilas
@ast
M Fatjó-Vilas
@en
M Fatjó-Vilas
@es
M Fatjó-Vilas
@nl
prefLabel
M Fatjó-Vilas
@ast
M Fatjó-Vilas
@en
M Fatjó-Vilas
@es
M Fatjó-Vilas
@nl
P106
P31
P496
0000-0001-9963-6241